PL2616064T3 - Gotowe do zastosowania formulacje ketorolaku - Google Patents

Gotowe do zastosowania formulacje ketorolaku

Info

Publication number
PL2616064T3
PL2616064T3 PL11835216T PL11835216T PL2616064T3 PL 2616064 T3 PL2616064 T3 PL 2616064T3 PL 11835216 T PL11835216 T PL 11835216T PL 11835216 T PL11835216 T PL 11835216T PL 2616064 T3 PL2616064 T3 PL 2616064T3
Authority
PL
Poland
Prior art keywords
ready
ketorolac formulations
use ketorolac
formulations
ketorolac
Prior art date
Application number
PL11835216T
Other languages
English (en)
Inventor
Joseph Pergolizzi
Alexander Mironov
Chad James Pickens
Douglas Giles Johnson
Original Assignee
Rtu Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rtu Pharmaceuticals Llc filed Critical Rtu Pharmaceuticals Llc
Publication of PL2616064T3 publication Critical patent/PL2616064T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL11835216T 2010-10-21 2011-10-21 Gotowe do zastosowania formulacje ketorolaku PL2616064T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40538410P 2010-10-21 2010-10-21
US201161481602P 2011-05-02 2011-05-02
PCT/US2011/057284 WO2012054831A2 (en) 2010-10-21 2011-10-21 Ready to use ketorolac formulations
EP11835216.0A EP2616064B1 (en) 2010-10-21 2011-10-21 Ready to use ketorolac formulations

Publications (1)

Publication Number Publication Date
PL2616064T3 true PL2616064T3 (pl) 2020-02-28

Family

ID=45973506

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11835216T PL2616064T3 (pl) 2010-10-21 2011-10-21 Gotowe do zastosowania formulacje ketorolaku

Country Status (19)

Country Link
US (5) US9421191B2 (pl)
EP (3) EP3632432B1 (pl)
JP (1) JP6013346B2 (pl)
KR (4) KR20190085561A (pl)
CN (2) CN108703948A (pl)
CA (1) CA2814805C (pl)
CY (1) CY1122516T1 (pl)
DK (1) DK2616064T3 (pl)
ES (2) ES2753981T3 (pl)
HR (1) HRP20191994T1 (pl)
HU (1) HUE045889T2 (pl)
LT (1) LT2616064T (pl)
MX (1) MX346879B (pl)
PL (1) PL2616064T3 (pl)
PT (1) PT2616064T (pl)
RS (1) RS59526B1 (pl)
SI (1) SI2616064T1 (pl)
SM (1) SMT201900656T1 (pl)
WO (1) WO2012054831A2 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE045889T2 (hu) 2010-10-21 2020-01-28 Rtu Pharmaceuticals Llc Használatkész ketorolak készítmények
US10098872B1 (en) 2013-07-22 2018-10-16 William Bradley Worthington Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
US11559521B2 (en) * 2013-07-22 2023-01-24 William Bradley Worthington Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
US11992485B2 (en) 2013-07-22 2024-05-28 Hutchison Health, Llc Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
US11992484B2 (en) 2013-07-22 2024-05-28 Hutchison Health, Llc Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CN103830171B (zh) * 2014-03-04 2015-11-18 鲁南制药集团股份有限公司 一种酮咯酸氨丁三醇注射液及其制备方法
CA2955229C (en) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
WO2016064873A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
CN113144218A (zh) * 2015-11-25 2021-07-23 艾克萨姆治疗公司 包含美洛昔康的药物组合物
IT201600075246A1 (it) * 2016-07-19 2018-01-19 Jointherapeutics S R L Composizioni comprendenti una matrice polisaccaridica per il rilascio controllato di principi attivi.
EP4650374A3 (en) * 2017-05-10 2026-03-04 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
FR3101917B1 (fr) 2019-10-09 2022-07-15 Ifp Energies Now Système de refroidissement à radiateur unique
CN110812325B (zh) * 2019-11-13 2022-04-05 鲁南制药集团股份有限公司 一种提高酮咯酸氨丁三醇注射液存储稳定性的方法
CN113679676A (zh) * 2020-05-19 2021-11-23 南京海融医药科技股份有限公司 一种左酮咯酸的药物组合物及其制备方法
CN114159384B (zh) * 2021-02-07 2023-04-07 南京锐志生物医药有限公司 一种化学性质稳定的低刺激性酮咯酸氨丁三醇注射液
TWI857310B (zh) * 2021-06-24 2024-10-01 大陸商上海雲晟研新生物科技有限公司 酮咯酸胺丁三醇的液體組合物、其製備方法及應用
CN113384524B (zh) * 2021-07-05 2025-08-12 四川尚锐生物医药有限公司 一种稳定的酮咯酸氨丁三醇注射液的制备方法
CN114191384A (zh) * 2021-12-20 2022-03-18 成都倍特药业股份有限公司 一种即用型酮咯酸氨丁三醇和氢溴酸依他佐辛组合液体制剂
CN114432240A (zh) * 2022-03-04 2022-05-06 郑州市中心医院 一种稳定不刺激的酮咯酸氨丁三醇注射液及其制备方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US5214052A (en) 1987-07-28 1993-05-25 Mitsubishi Kasei Corporation Method for dissolving arginineamides and pharmaceutical compositions containing them
KR100514963B1 (ko) 1997-07-11 2005-09-15 도레이 가부시끼가이샤 4,5-에폭시모르피난 유도체를 함유하는 안정한 의약품 조성물
US6608073B1 (en) 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
SK13742001A3 (sk) 1999-03-26 2002-02-05 Pozen Inc. Vysokoúčinné dihydroergotamínové prostriedky
US20040022787A1 (en) 2000-07-03 2004-02-05 Robert Cohen Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID
US6509027B2 (en) * 2001-02-12 2003-01-21 Supergen, Inc. Injectable pharmaceutical composition comprising coated particles of camptothecin
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
HRP20150037T4 (hr) 2003-04-08 2022-09-02 Progenics Pharmaceuticals, Inc. Farmaceutske formulacije koje sadrže metilnaltrekson
US20070049552A1 (en) 2003-04-14 2007-03-01 Babu Manoj M Fluoroquinolone formulations and methods of making and using the same
US20080317681A1 (en) * 2003-07-11 2008-12-25 Petros Gebreselassie Compositions containing a stain removing complex, and methods of making and using the same
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
DE602005027727D1 (de) 2004-10-15 2011-06-09 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
US8148356B2 (en) 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
IN2015DN03947A (pl) 2005-09-01 2015-10-02 Baxter Int
US20070142478A1 (en) * 2005-12-21 2007-06-21 Erning Xia Combination antimicrobial composition and method of use
WO2007092620A2 (en) 2006-02-09 2007-08-16 Macusight, Inc. Stable formulations, and methods of their preparation and use
DOP2007000055A (es) * 2006-04-10 2007-10-31 Senosiain S A De C V Lab Composición farmaceutica que comprende un analgésico y vitaminas
EP2012788A4 (en) 2006-04-18 2010-05-26 Ekr Therapeutics Inc PREPARED USE-READY INTRAVENOUS BOLUSA COMPOSITIONS AND USE METHOD
WO2007146795A2 (en) 2006-06-12 2007-12-21 Ironwood Pharmaceuticals, Inc. Pharmaceutical formulation for parenteral administration
JP2009542665A (ja) * 2006-06-29 2009-12-03 シェーリング コーポレイション 糖を含まない保存に安定な抗ヒスタミンシロップ
US20080014274A1 (en) 2006-07-14 2008-01-17 Wyeth Enhanced stability phenylephrine liquid compositions
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
US20080057023A1 (en) * 2006-08-29 2008-03-06 Chynn Emil W Oxygenated ophthalmic composition
JP5624766B2 (ja) 2006-09-27 2014-11-12 イーグル・ファーマシューティカルズ・インコーポレーテッド アルコールを含まないアルガトロバン製剤
KR100836624B1 (ko) 2006-12-08 2008-06-10 한국전자통신연구원 가변 고속 푸리에 변환 장치 및 그 방법
US20080312154A1 (en) * 2007-06-15 2008-12-18 Barbara Lee Peterlin Administration of adipocytokine and adiponectin for treating headache and methods of diagnosing headache by measuring adiponectin
AU2008296971B2 (en) 2007-09-03 2014-10-02 Nanoshift, Llc Particulate compositions for delivery of poorly soluble drugs
WO2009087658A2 (en) * 2007-11-07 2009-07-16 Sun Pharma Advanced Research Company Limited Composition suitable for parenteral administration
CA2705733C (en) 2007-11-13 2015-02-03 Cadence Pharmaceuticals Reduced dose intravenous acetaminophen
US20090239836A1 (en) * 2008-03-24 2009-09-24 Mary Lee Ciolkowski Multifunctional Ophthalmic Compositions
US8956636B2 (en) * 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Methods and compositions for treating postoperative pain comprosing ketorolac
US7635773B2 (en) * 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
TWI397038B (zh) * 2008-11-05 2013-05-21 Au Optronics Corp 使用半源極驅動架構之顯示面板及其顯示資料供應方法
EP3339190A1 (en) * 2010-07-19 2018-06-27 Biogen Chesapeake LLC Containers for glyburide solutions
MY173215A (en) 2010-07-21 2020-01-06 Cumberland Pharmaceuticals Inc Acetylcysteine compositions and methods of use thereof
HUE045889T2 (hu) 2010-10-21 2020-01-28 Rtu Pharmaceuticals Llc Használatkész ketorolak készítmények

Also Published As

Publication number Publication date
US9962371B2 (en) 2018-05-08
EP3632432A1 (en) 2020-04-08
CN108703948A (zh) 2018-10-26
EP2616064A2 (en) 2013-07-24
WO2012054831A3 (en) 2012-06-07
KR102307601B1 (ko) 2021-09-30
US20190105301A1 (en) 2019-04-11
US20120101142A1 (en) 2012-04-26
CN103167800A (zh) 2013-06-19
CA2814805A1 (en) 2012-04-26
WO2012054831A2 (en) 2012-04-26
EP4190327A1 (en) 2023-06-07
US20170007575A1 (en) 2017-01-12
MX346879B (es) 2017-04-03
KR20180119610A (ko) 2018-11-02
PT2616064T (pt) 2019-11-06
LT2616064T (lt) 2019-11-25
CA2814805C (en) 2021-11-02
CY1122516T1 (el) 2021-01-27
JP2013543843A (ja) 2013-12-09
EP2616064A4 (en) 2016-07-20
US20180280351A1 (en) 2018-10-04
MX2013004393A (es) 2014-09-12
HUE045889T2 (hu) 2020-01-28
US20220023260A1 (en) 2022-01-27
JP6013346B2 (ja) 2016-10-25
EP2616064B1 (en) 2019-08-07
DK2616064T3 (da) 2019-11-11
SMT201900656T1 (it) 2020-01-14
US11116750B2 (en) 2021-09-14
US10278959B2 (en) 2019-05-07
KR20140012029A (ko) 2014-01-29
ES2753981T3 (es) 2020-04-15
KR20200078541A (ko) 2020-07-01
KR20190085561A (ko) 2019-07-18
US9421191B2 (en) 2016-08-23
EP3632432B1 (en) 2022-09-14
RS59526B1 (sr) 2019-12-31
KR102114568B1 (ko) 2020-05-22
SI2616064T1 (sl) 2019-12-31
HRP20191994T1 (hr) 2020-02-07
ES2933198T3 (es) 2023-02-02

Similar Documents

Publication Publication Date Title
LT2616064T (lt) Parengtos naudoti ketorolako kompozicijos
GB201015271D0 (en) Improvements relating to wheelchairs
GB201010193D0 (en) Medicinal use
AU332760S (en) Spatula head
GB201101733D0 (en) Cosmetic composition
IL222637A0 (en) Alcohol-resistant formulations
TWI559935B (en) Cosmetic composition
GB201019441D0 (en) Improvements to hand irons
EP2620160A4 (en) COMPOSITIONS FOR ORAL ADMINISTRATION
GB201216277D0 (en) Oral supplement
GB201003218D0 (en) Improvements relating to platform devices
PL2407155T3 (pl) Formulacje inekalcytolu
ZA201300194B (en) Formulations
GB201018816D0 (en) Improvements in or relating to plugs
GB201110193D0 (en) Formulations
GB201013513D0 (en) Formulations
GB201004616D0 (en) Improvements relating to dispensers
ZA201300196B (en) Formulations
GB201018584D0 (en) Improvements in or relating to stairlifts
PL390147A1 (pl) Kompozycja kosmetyczna
AU2010100004A4 (en) Ready to serve oysters
GB201011738D0 (en) Further improvements to chair arrangement
GB201007702D0 (en) Formulations
GB201010494D0 (en) Formulations
GB201018649D0 (en) Formulations